Potentiation of antitumor activity of cyclophosphamide by centrophenoxine.
D000085:Acetates / Q000627:therapeutic use*; D000230:Adenocarcinoma / Q000188:drug therapy; D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy; D000697:Central Nervous System Stimulants / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000627:therapeutic use*; D004357:Drug Synergism; D005021:Ethylamines / Q000627:therapeutic use; D005260:Female; D007274:Injections, Intraperitoneal; D008297:Male; D002504:Meclofenoxate / Q000627:therapeutic use / Q000633:toxicity; D051379:Mice; D008937:Mitomycins / Q000008:administration & dosage / Q000627:therapeutic use; D009374:Neoplasms, Experimental / Q000188:drug therapy; D012513:Sarcoma, Experimental / Q000188:drug therapy
D000085:Acetates; D000970:Antineoplastic Agents; D000697:Central Nervous System Stimulants; D005021:Ethylamines; D008937:Mitomycins; D003520:Cyclophosphamide; D002504:Meclofenoxate